This study tests an experimental inhaler called taplucainium (NOC-110) in 455 adults with chronic cough that has lasted at least a year and hasn't been helped by other treatments. Participants will take the inhaler or a placebo once daily for several weeks. The main goal is to se…
Phase: PHASE2 • Sponsor: Nocion Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC